UNC13A and proximal spinal muscular atrophy: This mRNA editing thus indicates that therapies aimed at mitigating neuromuscular pathology in SMA may need to focus not only on increasing Munc13-1 protein levels but also on correcting mRNA transport and local translation processes to fully rescue synaptic functions.